Euro slides to 20-year low against the dollar as recession fears build

Euro slides to 20-year low against the dollar as recession fears build


A euro currency symbol sits on display in the visitor centre at the European Central Bank (ECB) building in Frankfurt, Germany.

Alex Kraus | Bloomberg | Getty Images

The euro fell to its lowest level in two decades on Tuesday, sliding over 1% to hit $1.0305.

It comes as fears of a recession in the euro zone ramp up, as gas prices soar and the Ukraine war shows no signs of abating.

Euro zone inflation hit a record 8.6% in June, prompting the ECB to give markets advance notice of its intention to hike interest rates for the first time in 11 years at its July meeting.

However, growing fears of a recession may limit the central bank’s capacity to tighten monetary policy. The July Sentix Economic Index on Monday showed investor morale across the 19-country euro zone has plunged to its lowest level since May 2020, pointing toward an “inevitable” recession.

The euro has lost over 9% of its value against the dollar since the start of the year.

This is a developing story and will be updated shortly.



Source

Investors usually ‘sell in May and go away.’ Why that may not work this year
World

Investors usually ‘sell in May and go away.’ Why that may not work this year

“Sell in May and go away?” Some market participants say it could be better to wait and see this year. The old stock market adage speaks to the phenomenon in which the May-through-October stretch has seasonally borne out to be the worst six-month period of returns for stocks. With traders leaving their desks during the […]

Read More
Jury selection kicks off in Musk v. Altman trial
World

Jury selection kicks off in Musk v. Altman trial

A combination image shows Sam Altman, CEO of OpenAI, during the Asia-Pacific Economic Cooperation (APEC) CEO Summit in San Francisco, California, U.S., on November 16, 2023 and Elon Musk, Chief Executive Officer of SpaceX and Tesla and owner of X, formerly known as Twitter during Viva Technology conference dedicated to innovation and startups at the […]

Read More
Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs
World

Pharma bets a little-known form of cholesterol will underpin its next blockbuster heart drugs

Pharma thinks it’s found the next frontier in preventing heart attacks.  Novartis, Amgen and Eli Lilly are among the drugmakers betting that slashing levels of a particularly bad form of cholesterol could deliver the next blockbusters in cardiology. All three of the pharmaceutical giants are in late-stage trials to test whether drugs that cut Lp(a) […]

Read More